Beximco Pharmaceuticals (LON:BXP) Trading 1.4% Higher – Should You Buy?

Shares of Beximco Pharmaceuticals Limited (LON:BXP) rose 1.4% on Thursday . The company traded as high as GBX 36.70 ($0.47) and last traded at GBX 36 ($0.46). Approximately 37,663 shares were traded during trading, a decline of 76% from the average daily volume of 157,696 shares. The stock had previously closed at GBX 35.50 ($0.45).

Beximco Pharmaceuticals Stock Performance

The firm’s 50 day simple moving average is GBX 30.53 and its 200-day simple moving average is GBX 33.20. The company has a market capitalization of £160.60 million, a PE ratio of 450.00 and a beta of 0.61. The company has a quick ratio of 0.37, a current ratio of 1.80 and a debt-to-equity ratio of 14.73.

About Beximco Pharmaceuticals

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.